Scientific ReportsPhysiologyPeer-reviewed journal article
Improved vascularized lymph node transfer by periodic injection of hyaluronidase in a rodent model
Hwayeong CheoniD, Linhai Chen, Sang Ah KimiD, Ma. Nessa GelvosaiD, Joon Pio HongiD, Jae Yong JeoniD, Hyunsuk Peter SuhiD
Abstract
BackgroundVascularized lymph node transfer (VLNT) is an advanced surgical approach for secondary lymphedema (SLE) treatment, but tissue fibrosis around the lymph node flap (VLNF) inhibiting lymphangiogenesis is the biggest challenge undermining its therapeutic efficacy. Hyaluronidase (HLD), which is an enzyme that breaks down hyaluronic acid, may have the efficacy of reducing fibrosis and increasing the chance of lymphangiogenesis in the injury site. Materials and methods52 Sprague-Dawley rats with VLNF were divided into a group injected periodically with HLD and a control group and followed up. A follow-up study was performed for 13 weeks starting 1 week after model formation was examined. The limb volume and dermal backflow pattern were observed to evaluate the degree of lymphedema. The real-time ICG fluorescence intensity changes were measured to evaluate the degree of lymphatic drainage to the flap. Lastly, the number of regenerative lymphatic vessels and the degree of fibrosis were investigated. ResultsIn the group injected with HLD periodically (VLNF+HLD group), swelling reduction and dermal backflow pattern recovery occurred rapidly in the 3rd week of follow-up compared to the only VLNF group. Moreover, the efficiency of lymphatic drainage into the flap was also improved in the VLNF+HLD group. They significantly had more newly formed lymphatic vessels along with a decrease in collagen fiber decomposition in the tissue around the VLNF by up to 26%. ConclusionThese encouraging results pave the way for developing a combination strategy for SLE treatment involving HLD and VLNT. Furthermore, this finding may guide future research on the development of new drugs that could enhance the efficacy of VLNT surgery for SLE patients. Graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=96 SRC="FIGDIR/small/586511v1_ufig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@12b4c7forg.highwire.dtl.DTLVardef@1ab4538org.highwire.dtl.DTLVardef@14d93adorg.highwire.dtl.DTLVardef@1a6b87_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 6
- FWCI
- 1.03
- Field percentile
- top 24%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lymph Node Dissection and Radiation in the Rat Popliteal Region Leads to Progressive Lymphatic Pump Failure and Lymphedema
Shao‐Yun Hsu, Young Jae Ryu, … J. Brandon Dixon·bioRxiv·Mar 14, 2026
- Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema
A. Lamaa, J. Creff, … B. Garmy-Susini·bioRxiv·Jan 5, 2023
- Dynamic interactions of lymphatic vessels at the hair follicle stem cell niche during hair regeneration
D. Pena-Jimenez, S. Fontenete, … M. Perez-Moreno·bioRxiv·Feb 13, 2019
- Fluid forces control structural remodeling of blind-ended lymphatic microvessels
Jacob C. Holter, Shashwat Agarwal, … Jonathan W. Song·Advanced Healthcare MaterialsPeer-reviewed·Apr 5, 2026
- A versatile microfluidic extrusion-based hydrogel platform for self-organization and long-term maintenance of engineered 3D lymphatic endothelium
Elsa Mazari‐Arrighi, Adeline Boyreau, … Pierre Nassoy·Advanced Healthcare MaterialsPeer-reviewed·Jun 3, 2026
- Cyperus rotundus root extract inhibits progress of lymphedema in mouse tail model
N. Pandey, P. Mishra, Y. B. Tripathi·bioRxiv·Oct 15, 2021